Of note, SARS-CoV-2-specific CD8+ T cells were found in at least 70% of convalescent COVID-19 patients [18], whereas their accelerated generation and egress into circulation during the acute phase of COVID-19 were closely related to mild COVID-19 [25]. This evidence concerns the gene CD8A and COVID-19.